Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-164625
Filing Date
2012-04-16
Accepted
2012-04-16 16:49:40
Documents
8
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d328204d10k.htm 10-K 184495
2 EXHIBIT 13.1 d328204dex131.htm EX-13.1 488545
3 EXHIBIT 23.1 d328204dex231.htm EX-23.1 1510
4 EXHIBIT 31.1 d328204dex311.htm EX-31.1 10250
5 EXHIBIT 31.2 d328204dex312.htm EX-31.2 10341
6 EXHIBIT 32.1 d328204dex321.htm EX-32.1 3552
7 EXHIBIT 32.2 d328204dex322.htm EX-32.2 3706
8 GRAPHIC g328204g63h92.jpg GRAPHIC 3658
  Complete submission text file 0001193125-12-164625.txt   708588
Mailing Address 718 GROVE ROAD MIDLOTHIAN VA 23114
Business Address 718 GROVE ROAD MIDLOTHIAN VA 23114 804-464-1601
COMMONWEALTH BIOTECHNOLOGIES INC (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 12761658
SIC: 8731 Services-Commercial Physical & Biological Research